Clinical Trials · NCT03512262

Safety and Efficacy of Abaloparatide-SC in Men With Osteoporosis (ATOM)

CompletedPhase 3Abaloparatide (Approved)
Phase
Phase 3
Recruitment status
Completed
Sponsor
Radius Health, Inc.
Enrollment
228
Start date
May 2018
Locations
34 sites, 3 countries
Primary endpoint
Percent Change From Baseline in Lumbar Spine BMD at Month 12
View Abaloparatide compound reference